Lyo Inuyama

Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study

Shuichi Kaneko, Kenji Ikeda, Yasushi Matsuzaki et al. · Journal of Gastroenterology · 2016 · 35 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16

A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance

Hideyuki Akaza, Mototsugu Oya, Masafumi Iijima et al. · Japanese Journal of Clinical Oncology · 2015 · 30 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Present Profiles of Novel Anticoagulant Use in Japanese Patients with Atrial Fibrillation: Insights from the Rivaroxaban Postmarketing Surveillance Registry

Satoshi Ogawa, Takanori Ikeda, Takanari Kitazono et al. · Journal of Stroke and Cerebrovascular Diseases · 2014 · 25 citations

Medicine, Cardiology, Pharmacotherapy +12

Design and baseline characteristics of the Xarelto Post‐Authorization Safety &amp; Effectiveness Study in Japanese Patients with Atrial Fibrillation (<scp>XAPASS</scp>)

Satoshi Ogawa, Kazuo Minematsu, Takanori Ikeda et al. · Journal of Arrhythmia · 2018 · 16 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14